Trophic factors GDNF and BDNF improve function of retinal sheet transplants.
The aim of this study was to compare glial-derived neurotrophic factor (GDNF) treatment with brain-derived neurotrophic factor (BDNF) treatment of retinal transplants on restoration of visual responses in the superior colliculus (SC) of the S334ter line 3 rat model of rapid retinal degeneration (RD). RD rats (age 4-6 weeks) received subretinal transplants of intact sheets of fetal retina expressing the marker human placental alkaline phosphatase (hPAP). Experimental groups included: (1) untreated retinal sheet transplants, (2) GDNF-treated transplants, (3) BDNF-treated transplants, (4) none surgical, age-matched RD rats, (5) sham surgery RD controls, (6) progenitor cortex transplant RD controls, and (7) normal pigmented rat controls. At 2-8 months after transplantation, multi-unit visual responses were recorded from the SC using a 40 ms full-field stimulus (-5.9 to +1 log cd/m(2)) after overnight dark-adaptation. Responses were analyzed for light thresholds, spike counts, response latencies, and location within the SC. Transplants were grouped into laminated or rosetted (more disorganized) transplants based on histological analysis. Visual stimulation of control RD rats evoked no responses. In RD rats with retinal transplants, a small area of the SC corresponding to the position of the transplant in the host retina, responded to light stimulation between -4.5 and -0.08 log cd/m(2), whereas the light threshold of normal rats was at or below -5 log cd/m(2) all over the SC. Overall, responses in the SC in rats with laminated transplants had lower response thresholds and were distributed over a wider area than rats with rosetted transplants. BDNF treatment improved responses (spike counts, light thresholds and responsive areas) of rats with laminated transplants whereas GDNF treatment improved responses from rats with both laminated and rosetted (more disorganized) transplants. In conclusion, treatment of retinal transplants with GDNF and BDNF improved the restoration of visual responses in RD rats; and GDNF appears to exert greater overall restoration than BDNF.
Yang
Pamela B
PB
Anatomy and Neurobiology, Univ. of California, Irvine, CA, USA.
Seiler
Magdalene J
MJ
Aramant
Robert B
RB
Yan
Fengrong
F
Mahoney
Melissa J
MJ
Kitzes
Leonard M
LM
Keirstead
Hans S
HS
D000818:Animals; D030801:Animals, Genetically Modified; D019208:Brain-Derived Neurotrophic Factor / Q000494:pharmacology*; D004594:Electrophysiology; D005074:Evoked Potentials, Visual / Q000502:physiology; D005260:Female; D016332:Fetal Tissue Transplantation; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000494:pharmacology*; D008297:Male; D008863:Microspheres; D010775:Photic Stimulation; D051381:Rats; D012160:Retina / Q000166:cytology / Q000502:physiology* / Q000637:transplantation*; D012162:Retinal Degeneration / Q000503:physiopathology / Q000601:surgery*; D013234:Stem Cells / Q000187:drug effects; D013477:Superior Colliculi / Q000502:physiology
D019208:Brain-Derived Neurotrophic Factor; D051100:Glial Cell Line-Derived Neurotrophic Factor
Exp Neurol. 2002 Mar;174(1):48-57
11869033
Brain Res. 1985 Jun;352(2):286-90
3896407
Cell. 1996 Jun 28;85(7):1113-24
8674117
Invest Ophthalmol Vis Sci. 2000 May;41(6):1546-53
10798675
J Neurosci. 1999 Jun 15;19(12):4778-85
10366612
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3480-8
12407159
J Neurosci Res. 1997 Nov 1;50(3):487-95
9364334
J Neurochem. 2007 Nov;103(3):1041-52
17935603
Prog Retin Eye Res. 2004 Sep;23(5):475-94
15302347
Mol Vis. 2005 Sep 01;11:677-87
16163265
Eur J Neurosci. 2005 Jan;21(1):161-72
15654853
Brain Res. 2005 Aug 9;1052(2):119-29
16018990
Mol Neurobiol. 2001 Aug-Dec;24(1-3):1-28
11831547
Development. 2005 Oct;132(19):4285-98
16141221
Trends Genet. 2005 Feb;21(2):103-10
15661356
Brain Res. 1985 Mar;351(1):129-34
3995334
Exp Eye Res. 2004 Jul;79(1):29-39
15183098
Neurology. 2003 Jan 14;60(1):69-73
12525720
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1669-76
11381076
Invest Ophthalmol Vis Sci. 1998 Oct;39(11):2121-31
9761291
J Neurobiol. 1999 Feb 15;38(3):382-90
10022580
J Neurochem. 2003 Oct;87(2):290-6
14511106
Ann Neurol. 2005 Feb;57(2):298-302
15668979
Prog Retin Eye Res. 1999 Nov;18(6):689-735
10530749
Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1686-95
12657610
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2724-34
10509671
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3383-92
16123443
Nat Biotechnol. 2001 Oct;19(10):934-9
11581658
Eur J Neurosci. 2010 Feb;31(3):508-20
20105230
Curr Gene Ther. 2007 Apr;7(2):121-9
17430131
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):267-74
14691183
Vision Res. 2002 Feb;42(4):393-9
11853755
Neuroscience. 2003;122(1):229-35
14596863
J Cell Biochem. 2003 Jan 1;88(1):57-75
12461775
Nature. 1990 Sep 6;347(6288):83-6
2168521
Am J Ophthalmol. 2008 Aug;146(2):172-182
18547537
Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3319-26
12356841
Dev Biol. 1999 Oct 1;214(1):128-38
10491262
Am J Hum Genet. 1998 Mar;62(3):503-8
9497269
Ophthalmologica. 2000 Jan-Feb;214(1):54-69
10657744
Development. 1993 Dec;119(4):1005-17
8306871
Biochemistry. 1983 Feb 1;22(3):653-60
6188482
Neurosci Lett. 2005 Sep 9;385(2):143-7
15950381
Mol Ther. 2001 Dec;4(6):622-9
11735347
Cell Tissue Res. 1996 Nov;286(2):191-207
8854888
Exp Eye Res. 2008 Jan;86(1):92-104
17983616
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3027-36
12202526
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3526-32
12882803
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4190-6
15505074
J Neurosci. 2000 Feb 15;20(4):1470-83
10662837
Optometry. 2009 Jul;80(7):384-401
19545852
Prog Retin Eye Res. 2002 Jan;21(1):57-73
11906811
J Neurosci Methods. 2010 May 15;188(2):250-7
20219535
Exp Eye Res. 1998 Jun;66(6):791-805
9657912
Eur J Neurosci. 2008 Jul;28(1):208-20
18662343
Cell Tissue Res. 2008 Jan;331(1):347-57
17912553